Following publication of the original article [1], the authors reported an error. The incorrect sex-specific incidences of GCA were published. The correct mean annual cumulative incidence was 22.0 (95% CI 20.6–23.5) for women and 10.5 (95% CI 9.5–11.5) for men; p-value < 0.001 unaffected by the error. Revised versions of Fig. 2 and Table 2 are provided in this correction. Additionally, in the results section (page 4, first section) we report results of a sub-analysis of an extended cohort (n = 881). The correct annual cumulative incidence for women in this group was 24.1 and for men 11.6.
Fig. 2
Annual cumulative incidence of giant cell arteritis (American College of Rheumatology (ACR) criteria fulfilled) in Bergen health area 1972–2012. Overall and ESR-specific cumulative incidence calculated as cases per 100,000 general population over the age of 50 years. Incidence by sex was calculated per 100,000 women or men, respectively, and incidence by the different age categories was calculated per 100,000 population of the same age categories (< 60 years, 60–69 years, 70–79 years and 80+ years). Points plotted represent raw incidence. Solid lines were estimated using the smoothing technique of a moving average of 5 years. ESR, erythrocyte sedimentation rate
Table 2
The incidence of giant cell arteritis (GCA) in Bergen health area 1972–2012
a Mean annual cumulative incidence
All time
1972–1992
1993–2012
Cumulative incidence
95% CI
Cumulative incidence
95% CI
Cumulative incidence
95% CI
All patients
16.7
(15.5, 18.0)
11.2
(9.8, 12.7)
22.5
(20.5, 24.7)
Sex
Female
22.0
(20.6, 23.5)
13.3
(11.8, 14.9)
31.2
(28.8, 33.7)
Male
10.5
(9.5, 11.5)
8.6
(7.4, 9.9)
12.4
(10.9, 14.0)
Age, years
< 60
2.8
(2.3, 3.3)
1.5
(1.0, 2.1)
4.1
(3.3, 5.0)
60–69
15.5
(14.4, 16.8)
10.9
(9.6, 12.4)
20.3
(18.4, 22.4)
70–79
34.5
(32.8, 36.4)
23.4
(21.4, 25.6)
46.2
(43.3, 49.2)
80+
26.8
(25.3, 28.4)
14.3
(12.8, 16.0)
39.9
(37.2, 42.7)
ESR, mm/hr
ESR < 85
8.2
(7.3, 9.1)
4.5
(3.7, 5.5)
12.0
(10.6, 13.6)
ESR > 85
8.4
(7.6, 9.3)
6.6
(5.5, 7.7)
10.4
(9.0, 11.8)
b Relative risk (RR) according to time, sex, age and ESR
1972–1992
1993–2012
RR
95% CI
p-value
RR
95% CI
p-value
Unadjusted
Time (years)
1.1
(1.1, 1.1)
< 0.001
1.0
(1.0, 1.0)
0.543
Sex
Time (years)
1.1
(1.1, 1.1)
< 0.001
1.0
(1.0, 1.0)
0.462
Sex (Male vs. Female)
0.6
(0.5, 0.8)
< 0.001
0.4
(0.3, 0.5)
< 0.001
Age
Time (years)
1.1
(1.1, 1.1)
< 0.001
1.0
(1.0, 1.0)
0.135
60–69 vs. < 60
7.2
(5.1, 10.6)
< 0.001
5.0
(3.9, 6.4)
< 0.001
70–79 vs. < 60
15.4
(11.0, 22.5)
< 0.001
11.3
(9.1, 14.3)
< 0.001
80+ vs. < 60
9.5
(6.7, 13.9)
< 0.001
9.8
(7.8, 12.4)
< 0.001
ESR
Time (years)
1.1
(1.1, 1.1)
< 0.001
1.0
(1.0, 1.0)
0.632
ESR (>median vs. <median)
1.4
(1.1, 1.9)
0.006
0.9
(0.7, 1.0)
0.116
Overall and ESR-specific cumulative incidence reported as cases per 100,000 background population over the age of 50 years. Incidence for sex reported per 100,000 women or men respectively, and incidence for the different age categories reported per 100,000 population of the same age categories (< 60 years, 60–69 years, 70–79 years and 80+ years). Relative risk calculated according to Poisson regression models for the two timeperiods 1972–1992 and 1993–2012
ESR Erythrocyte sedimentation rate
CI Confidence interval
×
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.
Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.
Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.
Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.
Update Innere Medizin
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.
